AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sudarshan Pharma Industries Ltd.

₹36.4 +$9.37 (+34.67%)
BSE · 16 Oct 2026 09:55 UTC
Previous Close
₹36.25
Day Range
₹35.06₹36.99
Year Range
₹18.5₹42.79
Market Cap
9.09B
AVG Volume
438.44K
Trailing/Forward PE
34.34/-
PEG ratio
-0.47
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Bombay Stock ExchangeIN
Revenue (INR) · TTM
02B4B6B8B25 Q325 Q426 Q1
SUDARSHAN.BO Revenue (INR) by quarter, trailing twelve months
PeriodRevenue (INR)
26 Q17.32B
25 Q47.03B
25 Q36.44B
Net Income (INR) · TTM
0100M200M300M25 Q325 Q426 Q1
SUDARSHAN.BO Net Income (INR) by quarter, trailing twelve months
PeriodNet Income (INR)
26 Q1251.22M
25 Q4232.25M
25 Q3209M
Operating Income (INR) · TTM
0200M400M600M25 Q325 Q426 Q1
SUDARSHAN.BO Operating Income (INR) by quarter, trailing twelve months
PeriodOperating Income (INR)
26 Q1518.61M
25 Q4475.28M
25 Q3451.99M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (INR) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Sudarshan Pharma Industries Ltd.
SUDARSHAN.BO
Stockpicker

Video analysis: SUDARSHAN.BO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SUDARSHAN.BO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.